Cargando…
The Molecular and Functional Characteristics of HLA-G and the Interaction with Its Receptors: Where to Intervene for Cancer Immunotherapy?
Human leukocyte antigen G (HLA-G) mediates maternal-fetal immune tolerance. It is also considered an immune checkpoint in cancer since it may mediate immune evasion and thus promote tumor growth. HLA-G is, therefore, a potential target for immunotherapy. However, existing monoclonal antibodies direc...
Autores principales: | Attia, Jiji V. D., Dessens, Charlotte E., van de Water, Ricky, Houvast, Ruben D., Kuppen, Peter J. K., Krijgsman, Daniëlle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698525/ https://www.ncbi.nlm.nih.gov/pubmed/33213057 http://dx.doi.org/10.3390/ijms21228678 |
Ejemplares similares
-
A Critical Assessment of the Association between HLA-G Expression by Carcinomas and Clinical Outcome
por: van de Water, Ricky B., et al.
Publicado: (2021) -
HLA-G: A New Immune Checkpoint in Cancer?
por: Krijgsman, Daniëlle, et al.
Publicado: (2020) -
Mapping Variation in Breast Cancer Screening: Where to Intervene?
por: Padilla, Cindy M., et al.
Publicado: (2019) -
Differential role of HLA-A and HLA-B, C expression levels as prognostic markers in colon and rectal cancer
por: Michelakos, Theodoros, et al.
Publicado: (2022) -
Human Leukocyte antigen-G (HLA-G) and gastrointestinal malignancy
por: Nazemalhosseini-Mojarad, Ehsan, et al.
Publicado: (2014)